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ABSTRACT 
 
Cancer contributes substantially to overall mortality and morbidity worldwide, resulting in 
considerable research focused on treatments. Yet many types of cancers continue to have a 
poor prognosis1. Cancer is an incredibly diverse affliction, resulting from numerous changes in 
normal cell physiology. Treating such a diverse disease will take highly interdisciplinary work 
from clinicians and scientists to discover novel methods to fight this condition and improve 
existing treatments. The broad objective of this work is to obtain a better understanding of the 
actions of type I interferons (IFN), cytokines that display potent antiviral as well as anti-cancer 
activity. IFN has a variety of cellular effects, some of which lead to its anti-tumor nature, but 
many of which are not fully understood. Some cellular effects may contribute to the detrimental 
side effects that may occur during IFN treatment and significantly affect a patient’s quality of life. 
Thus, additional research is needed to improve the use of IFN as a cancer treatment. 
This work sheds light on type I interferon’s (IFN) effects on cellular endocytosis. 
Endocytosis, a vital process in healthy cells used to internalize material, is a likely IFN target. 
The anti-tumor nature of IFN may be an unintentional byproduct of its antiviral effects, which are 
designed to halt pathogenic assault, including pathogen entry into the cell via endocytosis2,3. 
IFN-induced effects on endocytosis may also contribute substantially to its anti-tumor nature, as 
abnormal endocytosis has also been found in multiple cancers4,5. To examine the effects of IFN 
on endocytosis, several fluorescent techniques were used to quantify the internalization of 
cholera toxin in IFN-treated and untreated cells. Flow cytometry was used to quantify the 
internalization of fluorescent pathway-specific cholera toxin with established  concentrations6, 
and the differences between the IFN-treated and untreated cell samples were assessed with 
statistical methods. The commercially available fluorescent reagent, 1,1'-dioctadecyl-3,3,3',3'-
tetramethylindodicarbocyanine, 4-chlorobenzenesulfonate (DiD) was also used to stain the 
plasma membrane and fluorescent-labeled cholera toxin to image IFN-treated and untreated 
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cells with confocal microscopy. This work showed that IFN induced a statistically significant 
increase in the endocytosis of cholera toxin in NIH-3T3 cells.   
This work not only expands the basic knowledge of IFN and its cellular effects, but also 
further characterizes a potential IFN target, namely endocytosis. This knowledge may lead to its 
improved use as a cancer treatment, and may also benefit gene/drug delivery research. 
Elucidating these IFN-induced changes in endocytosis may also lead to improved therapies 
which mimic IFN’s effects while bypassing adverse side effects.  
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CHAPTER 1: INTRODUCTION 
1.1 Interferon 
Interferon (IFN) is comprised of a family of signaling molecules secreted by cells that initiate 
immune responses against invading pathogens. While there are multiple types of IFN, this work 
focuses on Type I IFN due to their importance in medicine, specifically in cancer treatment, and the 
extent of research available. Type I IFN is comprised of IFN-α and IFN-β, which display potent antiviral 
activity. IFN has diverse effects, including manipulation of cellular metabolism, activation of immune 
counterparts, and antiproliferative effects7,8. IFN stimulates over 300 genes that detect viral molecules 
and modulate signaling pathways to block viral replication7.  
Type I IFN gene transcription is induced when cells detect foreign pathogens. This detection occurs 
through numerous pathways, however, only the most commonly reported methods will be discussed 
due to the complexity of the IFN signaling pathway. In the classical pathway, retinoic acid-inducible 
gene 1 (RIG-1), an intracellular receptor, recognizes viral RNA9–11. This recognition causes a 
conformation change of RIG-1 that leads to a signaling cascade responsible for the transcription of IFN 
genes9,10. Pathogens can also be recognized by toll-like receptors (TLRs). TLRs are members of a 
family of receptors that are located within numerous areas of the cell such as the plasma membranes, 
organelles, and cytosol9. TLRs recognize a variety of pathogen-associated molecules derived from 
viruses, bacteria, fungi, and protozoa12–14. TLR pathogen recognition also triggers a signaling cascade 
which leads to the transcription of IFN genes9. Following the production of IFN from cells which detect a 
pathogen, IFN can signal other neighboring cells in a paracrine-type fashion. Type I IFN interacts with 
the IFN-α/β receptor (IFNAR) located at the plasma membrane. Binding of IFN to IFNAR activates the 
heavily researched JAK-STAT signaling pathway, leading to a signaling cascade which activates 
hundreds of target genes7,9.   
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Figure 1.1: IFN production and signaling. Induction of type I IFN (IFN-α and IFN-β) is regulated by 
pathogen recognition receptors. TLRs are located in various regions on and within cells and are 
activated by unique pathogen-associated molecular patterns (PAMPs). RIG-I is a helicase and cytosolic 
sensor for viral RNA. RIG-I interacts with ssRNA and dsRNA. IFN-α and IFN-β are recognized by the 
IFNAR1/2 receptor, activating the JAK/STAT1 pathway. Reprinted by permission from Nature 
Publishing Group: [Kidney International] (Ref.11), copyright (2010)). 
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IFN induces a multitude of effects within a cell which serve to protect it from perceived pathogens. 
IFN is not only an important aspect of our immunity against pathogens, but holds promise as a 
therapeutic agent. Not surprisingly, clinicians have leveraged the powerful effects of IFN against a 
variety of disorders, most notably cancer. Continued research will strengthen our current understanding 
of IFN and help discern its diagnostic potential.  
1.2 Interferon as a Cancer Treatment 
Cancer is the second leading cause of death in the United States with costs estimated near $125 
billion in 2010 and a projected increase of nearly 27% by 20201,15. Type I IFN are not only crucial 
cytokines that mediate a host’s innate immune defense against pathogens, but are clinically important 
in the fight against many solid tumors and hematological malignancies such as melanoma, renal cell 
carcinoma, hairy cell leukemia, follicular lymphoma and AIDS-related Kaposi’s sarcoma16. 
Unfortunately, cancer treatment with IFN also carries adverse side effects which can substantially affect 
a patient’s quality of life. These can range from various constitutional effects, such as fatigue17, 
headache, and malaise16, to more severe symptoms indicative of neurological-18, hepatic- and 
hematologic-toxicity19 and autoimmune-mediated thyroid dysfunction20. These unwanted reactions 
show the great need for continued IFN research as a viable cancer treatment. 
Type I IFN are obvious candidates for anti-cancer therapy due to their regulation of innate and 
adaptive immunity which could enhance a patient’s natural abilities to fight cancerous cells, and its 
antiangiogenic and proapoptotic effects21. IFN has also been linked to cell growth, a key process for 
tumorigenesis, through p27, a tumor suppressor that plays an important role in regulating progression 
through the G1–S phases of the cell cycle22. 
While IFN holds promise as a cancer treatment, both clinical and basic research demonstrate the 
enormous complexity surrounding IFN and highlight our incomplete understanding of these cytokines. 
IFN has been used to treat melanoma, a form of skin cancer responsible for the vast majority of skin 
cancer deaths. An IFN subtype was found to significantly improve disease-free survival among 
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melanoma patients, however, significant side effects and conflicting data regarding the overall survival 
lead many clinicians to question its use as a treatment23. IFN has also been used for nearly three 
decades in the treatment of multiple myeloma24, a cancer of the plasma cells25. While its long-standing 
use as treatment certainly underscores the importance of IFN in myeloma treatment, many conflicting 
reports have surfaced detailing the inconsistencies reported among clinical studies and the efficacy of 
IFN treatment26–31. The disparities evident in the literature only serve to highlight the need for continued 
IFN research.  
1.3 Linking Interferon and Endocytosis  
While the clinical applications of IFN are heavily investigated, the direct mechanisms conveying the 
wanted, as well as the unwanted, effects of IFN treatment remain unclear. Endocytosis, a vital cellular 
process to internalize various materials including nutrients, membrane components, metabolites, and 
extracellular ligands32,33 is suspected to be a process targeted by IFN34,35. Endocytosis is important to 
many cellular functions aside from its obvious function of internalization, such as the regulation of cell-
surface receptor expression, maintenance of cell polarity, and cellular metabolite homeostasis36. 
Aberrant endocytosis has been found to be a hallmark of multiple cancers4,5. Dysfunction of important 
endocytosis machinery such as caveolin-1 (CAV-1), the characteristic caveolae-mediated endocytosis 
membrane protein, and Huntingtin interacting protein-1, HIP1, a known clathrin-binding protein that 
serves as a cofactor for clathrin-mediated endocytosis, has been shown in some cancers37. 
Upregulation of CAV-1 has been found to correlate with aggressive, metastatic tumors38. This CAV-1 
dysfunction has also been linked with poor prognosis in prostate cancers38,39. Overexpression of HIP1 
has been linked to lymphomas40, prostate and colon cancer41, primary breast tumors42, and gliomas43.  
More and more research points to complex functions of endocytosis that contribute far more to cell 
biology than merely the process of internalization. Among other things, endocytosis serves to regulate 
signaling, sort vital biomolecules to their proper places within the cell, and control morphogenetic 
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aspects. Aberrant control of such processes could account for the metastatic nature and abnormal 
signaling displayed by some tumor cells4,5,44. 
Research has shown IFN treatment markedly reduces the penetration of vesicular stomatitis virus 
into cells without affecting the adsorption of virus to the cell surface, an observation consistent with IFN-
specific regulation of endocytosis35. IFN has the potential to block entry of liposome-DNA complexes45 
and is implicated in the reduced efficiency of adenovirus-aided gene delivery46. The antiviral state 
naturally induced by IFN could limit the endocytosis of material in order to protect the cell from 
perceived invading pathogens, a manipulation likely induced in healthy and cancerous cells upon IFN 
treatment. Limiting internalization could slow cell growth due to the decrease in nutrients and signaling 
factors necessary to proceed through the cell cycle. A decrease in cell growth rate could directly 
account for the antitumor nature of IFN as an increased rate of cell growth is required to support the 
rapid proliferation central to tumor growth47.  
Caveolae are 50-100 nm flask-like invaginations located in lipid-specific plasma membrane 
microdomains and are heavily implicated as an important endocytosis route48–51. This endocytosis 
pathway is known to be a key entry point for virus, including influenza, Simian virus 40, and ebola virus 
making it a promising IFN target52,53. Caveolae are found within plasma membrane microdomain 
regions that are believed to be enriched in sphingolipids and cholesterol54. CAV-1 is a protein found in 
caveolae that is responsible for the de novo formation of caveolae55. This integral membrane protein 
also binds cholesterol56. These findings have led many researchers to speculate that CAV-1 is central 
to the structure and function of caveolae56–58. The cholesterol-binding properties of CAV-1 highlight the 
intimate relationship between plasma membrane cholesterol levels and caveolae endocytosis. In fact, 
cholesterol depletion causes disassembly of caveolae leading to disruption of the normal caveolae 
shape58. The control of cholesterol and sphingolipids could provide a means to control caveolae 
endocytosis.  
Recent research suggests a link between IFN-induced proteins and cellular membrane components 
that are important to the shape and function of caveolae, such as cholesterol and lipids, as well as their 
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biosynthesis pathways59,60. IFN has also been found to decrease plasma membrane fluidity61, implying 
modulation of plasma membrane molecular components. Furthermore, viperin, an IFN-inducible protein 
known to inhibit influenza infection, reduces the activity of an enzyme involved in cholesterol 
biosynthesis62,63. These findings suggest a link between IFN and plasma membrane components vital 
to caveolae. Though the precise mechanisms for the antiviral effects of down regulated sterol 
biosynthesis have not been established, the abundance of cellular cholesterol is known to affect 
caveolae which is also essential for virus infection64,65. Distinct membrane microdomains that are 
enriched with cholesterol have been associated with caveolae, and cholesterol-depletion induced 
disruption of these microdomains may underlie these changes in endocytosis66. Reorganization of 
membrane components and the alteration of cholesterol and lipid cellular concentrations could provide 
a means to control caveolae, bolstering our theory that IFN is modulating endocytosis.   
1.4 Flow Cytometry 
Flow cytometry enables the rapid study of single-cell characteristics using the optical properties of 
cells and fluorescence. In this technique, cells are labeled either with a fluorescent dye that binds 
specific cell regions, such as cellular DNA, or antibodies which have been fluorescently labeled. Once 
prepared cells are suspended, they are drawn into the flow cytometer which uses a sheath isotonic fluid 
stream, known as simply “sheath fluid”, to surround the cell suspension and create a laminar flow 
(Figure 1.2). This laminar flow enables single cells to pass through the laser beam to detect single-cell 
fluorescence. Cells emit light in all directions and a series of filters and mirrors are used to isolate 
specific wavelength bands. Photomultiplier tubes detect these light signals and convert them for digital 
analysis67. 
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Figure 1.2: Schematic of a flow cytometer. Sheath fluid is used to focus the single cell suspension to 
intersect a laser. Signal collection occurs via a forward angle light scatter detector, a sidescatter 
detector (1), and fluorescence emission detectors (2–4)67. Reprinted by permission from P.B. HOEBER: 
[Clinical Chemistry] (Ref. 67), copyright (2000)). 
 
Information from the detected light signals are typically converted and viewed as a histogram or 
two-dimensional dot plot. The way light is scattered enables not only the fluorescent molecules bound 
to the cell to be quantified, but also the size of the cell. Flow cytometry is a versatile tool used to 
analyze a cell’s size, DNA and RNA content, and the expression levels of a host of plasma membrane-
bound or cytosolic proteins67. 
1.5 Laser Scanning Confocal Microscopy  
Fluorescence microscopy is a commonly used technique which provides real-time visualization of 
fluorescently labeled molecules. Today, researchers are afforded a wide spectral range of commercially 
available fluorophores68. This allows simultaneous imaging of several different fluorescent molecules 
within cells. Laser scanning confocal microscopy (LSCM) allows optical sectioning of specimen where a 
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spatial filter, such as a pinhole, is used to eliminate undesired fluorescence above and below the focal 
plane of interest (Figure 1.3). This allows only fluorescence from the focal point of interest to reach the 
photodetector69.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1.3: The light path in a typical LSCM showing the pinholes placements to produce optical 
sectioning. Note the pinhole at the light source and the pinhole in front of the detector are all confocal 
with one another70. Reprinted by permission from Springer: [Molecular Biotechnology] (Ref. 70), 
copyright (2000)). 
 
LCSM allows imaging of fixed intervals within a specimen with both lateral and vertical axis, 
creating what are known as z-series or z-stacks. These z-stack images can be digitally combined to 
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produce three-dimensional images of the specimen70. LCSM is a powerful tool to visualize key 
structural components.   
1.6 Objectives of this Work 
To improve IFN as a cancer treatment we must better understand the intricacy involved in IFN-
induced cellular changes, such as its effects on endocytosis, and how these changes disrupt normal 
cell physiology. Understanding these complex relationships will lead to better knowledge of the tumor-
fighting capabilities of IFN, as well as how these IFN-induced changes contribute to adverse side 
effects. This thesis aims to characterize the key changes in important endocytosis pathways induced by 
IFN. This study will broaden the current knowledge of IFN and the regulation of endocytosis. 
Knowledge of these mechanisms could provide the rationale for the design of new cancer treatments 
that exploit similar pathways while minimizing adverse side effects. Understanding the cellular effects of 
IFN will not only improve clinical applications, but further basic immunology research. Advances in 
immunology could help in the fight against common immune disorders as well as provide insights into 
pathogen clearance that could pave the way for new drug treatments and therapies. Knowledge of the 
mechanisms by which the innate immune system thwarts viral entry can provide the rationale for the 
design of not only new antiviral treatments that exploit similar pathways, but also shed light on the IFN-
induced cellular responses that must be suppressed to achieve more efficient gene and drug delivery. 
 The overall goal of this work is to elucidate type I IFN effects on cellular endocytosis. The specific 
aim focuses on understanding the effects of type I IFN on caveolae-mediated endocytosis. This work 
characterizes the extent of IFN control on endocytosis, namely through caveolae-mediated pathways.  
Chapters 2 and 3 provide a detailed methodology and discussion of the experimental results. Briefly, 
commercially available IFN-αA/D (Sigma), a recombinant universal type I interferon hybrid which is able 
to cross the species barrier, was used to stimulate the IFN response using established literature to 
estimate the desired IFN concentration and time of treatment60,71. Flow cytometry was used to quantify 
the internalization of fluorescent pathway-specific cholera toxin with established  concentrations,6 and 
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the differences between the IFN-treated and untreated cell samples were assessed with statistical 
methods. The results of the flow cytometry were confirmed by imaging the plasma membrane, which 
was stained with the commercially available fluorescent reagent, 1,1'-dioctadecyl-3,3,3',3'-
tetramethylindodicarbocyanine, 4-chlorobenzenesulfonate (DiD), with respect to the fluorescent-labeled 
cholera toxin using confocal microscopy. This work showed that IFN induced a statistically significant 
increase in the endocytosis of cholera toxin in NIH 3T3 cells.  This finding refutes the original 
hypothesis that IFN treatment decreases caveolae-dependent endocytosis. Lastly, in Chapter 4 we 
discuss our conclusions and provide future directions.  
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CHAPTER 2:  INTERFERON UP-REGULATES THE INTERNALIZATION OF CHOLERA-TOXIN IN 
MURINE NIH 3T3 FIBROBLAST CELLS 
2.1 Introduction 
The objective of this work was to determine whether interferon (IFN) limits caveolae -dependent 
endocytosis, potentially explaining the anti-cancer effects IFN displays. Limiting caveolae-dependent 
endocytosis may primarily serve to limit virus’ entry into cells, helping to slow infection and prevent the 
spread of the virus into healthy cells; however, this manipulation of an important uptake pathway could 
result in other consequences. Fluorescence Activated Cell Sorting (FACS) techniques were used to 
investigate the internalization of caveolae-specific cholera toxin-conjugated Alexa Fluor 488 (CTx-488) 
in IFN treated and untreated cells. Cholera toxin was chosen as the uptake marker as it is known to 
enter cells through caveolae72,73. Both live and fixed cells were chosen for study and numerous FACS 
experiments were undertaken to ensure errors did not contribute to the observed trend.  
2.2 Materials and Methods 
2.2.1 Reagents 
Interferon-αA/D (IFN-αA/D) and sterile trypan blue solution were purchased from Sigma-Aldrich. 
Alexa Fluor 488-conjugated cholera toxin subunit B (CTx-488) was purchased from Invitrogen. 
Paraformaldehyde at 16% solution was purchased from Electron Microscopy Sciences. Dulbecco's 
Modified Eagle Medium (DMEM) without phenol red from Gibco was used during flow cytometry 
analysis. 
 
2.2.2 Cell Culture 
NIH 3T3 cells, a mouse fibroblast cell line, were obtained from the American Type Culture 
Collection (ATCC). Cells were grown at 37 °C in a humidified incubator with 5% CO2 in DMEM 
supplemented with 10% calf serum and 1% penicillin-streptomycin. Cells were cultured in 150x20 mm 
sterile cell culture dishes from Sarstedt.  
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2.2.3 Cell Preparation for Flow Cytometry and Flow Cytometry Analysis 
To investigate the caveolae-mediated endocytosis pathway and its response to IFN treatment, 
commercially available IFN-αA/D (Sigma) was used to treat NIH 3T3 murine fibroblast cells over 
several days. IFN-αA/D is a recombinant universal type I IFN hybrid and was used due to its ability to 
cross the species barrier. IFN treatment concentrations were chosen based on literature60,71. One day 
prior to IFN treatment, cells were seeded in 60x15 mm sterile culture dishes from BD Falcon. Following 
IFN treatment of 1000 U/mL in cell growth media for 0, 24, or 48 h at 37 °C, 2 μg/mL CTx-488 in cell 
growth media was placed in the cell dishes for 30 min at 37 °C74. Following CTx-488 treatment, cell 
samples were washed several times with Phosphate buffered saline (PBS), fixed with 4% 
paraformaldehyde for 10 min at room temperature, and analyzed in PBS with a BD FACS Aria II 
enclosed in a biosafety level 2 cabinet (10,000 events). Some fixed cell samples were also analyzed in 
trypan blue solution (data indicated below). Live cell samples were washed several times in PBS and 
analyzed in 1:1 trypan blue:DMEM without phenol red supplemented with 10% calf serum (data 
indicated below). Live cell samples were kept on ice following preparation until actual analysis. Flow 
cytometry data was analyzed using FCS Express 3 flow cytometry software.  
 
2.2.4 Flow Cytometry Quantification and Statistics 
One-way ANOVA with repeated measures analysis was performed using GraphPad Prism 
Statistical Software. A Tukey’s Multiple Comparison Test was also performed using GraphPad Prism 
Software to assign p-values to individual groups compared to the 0 h IFN sample. P-values are 
indicated in all figures by asterisks: *p<0.01 and **p<0.001. 
2.3 Results and Discussion 
As shown in Figure 2.1, CTx-488 uptake increased with increasing duration of IFN exposure. One-
way ANOVA with repeated measures analysis performed using GraphPad Prism Statistical Software 
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indicated the observed trend of increasing CTx-488 uptake was statistically significant (p-
value<0.0001).  
 
 
 
 
  
 
 
 
 
Figure 2.1: IFN up regulates endocytosis of CTx-488 in 3T3 fixed murine fibroblast cells. (A) 
Histograms show the mean value of each measurement (B) Values are the mean and standard error of 
the mean (SEM) from two separate experiments with duplicate samples. Differences from 0 h were 
found to be statistically significant at *p<0.01 and **p<0.001. 
 
A Tukey’s Multiple Comparison Test was also performed using GraphPad Prism Software to assign p-
values to individual groups compared to the 0 h IFN sample. This finding is the opposite of the original 
hypothesis that IFN treatment would decrease caveolae-dependent endocytosis.  
This unexpected trend calls into question the methods employed. A major question that had to be 
addressed was whether the increasing trend was merely due to errors associated with the FACS 
fluorescence detection, such as whether bound excess CTx-488 on the outside of the cell, but not 
internalized, was responsible for the trend. To evaluate the contribution of bound CTx-488, fixed cells 
were analyzed in trypan blue. Because trypan blue is a florescence quencher that cannot cross intact 
plasma membranes75,76, the fluorescence from surface-bound CTx-488 would be quenched by trypan 
blue, and only endocytosed CTx-488 would be detected. As shown in Figure 2.2, CTx-488 uptake again 
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increased with increasing duration of IFN exposure. One-way ANOVA performed using GraphPad 
Prism Statistical Software indicated the observed trend of increasing CTx-488 uptake was statistically 
significant (p-value<0.0001). A Tukey’s Multiple Comparison Test was also performed using GraphPad 
Prism Software to assign p-values to individual groups compared to the 0 h IFN sample. This finding 
supports the original findings shown in Figure 2.1.  
 
 
 
 
 
 
 
 
 
 
Figure 2.2: IFN up regulates endocytosis of CTx-488 in 3T3 fixed murine fibroblast cells analyzed in 
trypan blue. (A) Histograms show the mean value of each measurement (B) Values are the mean and 
standard error of the mean (SEM) from one experiment. Differences from 0 h were found to be 
statistically significant at *p<0.01. 
 
Although the importance of the trends shown in Figures 2.1 and 2.2 should not be minimized, it 
should be noted that fixed cells were used to gather this data. The question of whether this trend could 
be shown in living cells is important. Some fixation techniques can lead to the detection of background 
fluorescence which could impact the data gathered from FACS. Fixation with formaldehyde, 
specifically, has also been shown to distort cells77. Paraformaldehyde is merely a higher polymer weight 
of formaldehyde78. Formaldehyde is a highly reactive species, interacting with a multitude of different 
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functional groups of biological molecules such as glycoproteins77, a major constituent of a cell’s plasma 
membrane79. Research has demonstrated that formaldehyde can form plasma membrane vesiculation, 
the accumulation of fluid-filled vesicles at the plasma membrane77,80. These artifacts and drastic 
distortions evident from fixation call into question the actual similarities between fixed and live cells. If 
fixation causes major changes within the cells plasma membrane, the entry of excess CTx-488 through 
means such as diffusion, instead of genuine endocytosis, is a real concern.  
To investigate the effects of fixation on CTx-488 internalization, live cells were treated as described 
above, excluding fixation, and trypan blue was added prior to FACS analysis. Again, trypan blue was 
used as a florescence quencher to mitigate the fluorescence from surface-bound CTx-488 as it would 
be quenched, and only endocytosed CTx-488 would be detected. As shown in Figure 2.3, the same 
increase in CTx-488 uptake with increasing duration of exposure to IFN was observed. One-way 
ANOVA with repeated measures analysis performed using GraphPad Prism Statistical Software 
indicated the observed trend was statistically significant (p-value<0.0001). This data supports the 
earlier finding that caveolae-dependent endocytosis increases as the duration of time that the cells 
were exposed to IFN increases. A Tukey’s Multiple Comparison Test was also performed using 
GraphPad Prism Software to assign p-values to individual groups compared to the 0 h IFN sample. 
This finding supports the original findings found in fixed samples. 
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Figure 2.3: IFN up regulates endocytosis of CTx-488 in 3T3 live murine fibroblast cells. (A) Histograms 
show the mean value of each measurement (B) Values are the mean and standard error of the mean 
(SEM) from three separate experiments with duplicate samples. Differences from 0 h were found to be 
statistically significant at *p<0.01 and **p<0.001. 
 
The data presented in Figures 2.1-2.3 provide evidence in disagreement with the hypothesized role 
of IFN in the regulation of endocytosis. The increasing endocytosis of CTx-488 after treatment with IFN 
goes against the hypothesis that IFN would decrease caveolae in order to prevent pathogen entry. 
Several errors that may have contributed to the unexpected trend, such as the detection of 
fluorescence material on the outside of the cell, have been invalidated. These findings suggest a true 
trend was found. 
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CHAPTER 3: CONFOCAL MICROSCOPY CONFIRMS THE TRENDS FOUND USING FLOW 
CYTOMETRY 
3.1 Introduction 
While the data discussed in Chapter 2 provide evidence in support of a real trend, it contradicts 
expected predictions. Caveolae is a major entry pathway of numerous pathogens including influenza, 
Simian virus 40, and ebola virus52,53. Because IFN is theorized primarily to be an anti-virus tool a cell 
uses to prevent or limit infection7,8, the up-regulation of caveolae-dependent endocytosis seems 
counterintuitive. This makes the use of a second technique to verify the trend essential. Confocal 
microscopy serves as a powerful tool, enabling researchers to directly observe internal objects with 
excellent resolving capabilities. Although trypan blue was used to verify the internalization of CTx-488 
during FACS, confocal microscopy enables the ability to clearly distinguish internal and external 
compartments of a cell, provided an appropriate dye is available, by eye.  
To verify the internal location of the fluorescent CTx-488, DiD membrane stain was used to 
visualize the plasma membrane of the cells. Using a confocal scanning laser microscope, it was shown 
that CTx-488 was, in fact, located within the cell. This technique also enabled the visualization of the 
entire plasma membrane to ensure its integrity, providing evidence that the cell plasma membranes 
were intact and CTx-488 had entered cells through active endocytosis as opposed to pores or 
membrane breaks. 
3.2 Materials and Methods 
3.2.1 Reagents 
Interferon-αA/D (IFN-αA/D) was purchased from Sigma-Aldrich. Alexa Fluor 488-conjugated cholera 
toxin subunit B (CTx-488) and 1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine, 4-
chlorobenzenesulfonate (DiD) plasma membrane stain were purchased from Invitrogen. 
Paraformaldehyde at 16% solution was purchased from Electron Microscopy Sciences.  
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3.2.2 Cell Culture 
NIH 3T3 cells, a mouse fibroblast cell line, were obtained from the American Type Culture 
Collection (ATCC). Cells were grown at 37 °C in a humidified incubator with 5% CO2 in DMEM 
supplemented with 10% calf serum and 1% penicillin-streptomycin. Cells were cultured in 150x20 mm 
sterile cell culture dishes from Sarstedt.  
 
3.2.3 Cell Preparation for Laser Confocal Microscopy and Imaging 
NIH 3T3 cells were treated for 0, 24, or 48 h IFN at 1000 U/mL in cell growth media. One day prior 
to imaging, cells were seeded in 35 mm high glass bottom μ-DishesTM from Ibidi. On the day of 
imaging, cells were washed with PBS and then incubated with 2 μg/mL CTx-488 in growth media for 30 
min at 37 °C. Next, cells were washed three times with PBS and fixed with 4% paraformaldehyde 
solution for 25 min. The staining solution was made using 5 μL DiD dye diluted in 1 mL of growth media 
and was placed on the fixed subconfluent cell layers. The dye was incubated with the fixed cells for 10-
15 min at 37 °C. Following incubation, the dye solution was drained and cells layers were washed with 
PBS and incubated with warmed growth media for 10 min at 37 °C. This cycle of washing with PBS and 
incubation with growth media was repeated three times. Cells were imaged in PBS on a Carl Zeiss 
LSM700 confocal microscope with 63X1.4 NA oil immersion objective lens. A 488 nm laser and a 633 
nm laser were used for excitation of CTx-488 and DiD, respectively. 
3.3 Results and Discussion 
Following 30 min of incubation at 37 °C, CTx-488 is internalized by NIH 3T3 cells. Using a confocal 
scanning laser microscope, it was shown that CTx-488 was located within the cell cytosol. DiD plasma 
membrane stain is a lipophilic dye which binds cell plasma membrane81.  As shown below in Figure 3.1, 
the DiD membrane dye clearly delineates the plasma membrane, showing the CTx-488 located in the 
cell cytosol. The integrity of the cell plasma membrane is also upheld, as we see minimal red DiD stain 
located in the cell cytosol. This was important to show that cells were actively internalizing CTx-488, as 
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opposed to CTx-488 diffusing through pores or breaks within the cell plasma membrane. This data 
supports the FACS data shown in Chapter 2, proving CTx-488 is clearly entering the cells through 
active endocytosis means. 
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Figure 3.1: Confocal scanning laser microscopy images showing CTx-488 (green) and DiD (red) 
staining in fixed 3T3 murine fibroblast cells. The plasma membrane is clearly stained red and the green 
CTx-488 is located in the cytosol. (A-B) Control cells. (C-D) Cells treated with IFN for 24 h. (E-F) Cells 
treated with IFN for 48 h. 
A  B 
D C  
E  F  
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The data presented thus far suggest an increase in caveolae-mediated endocytosis following 
treatment with IFN. As previously explained this trend is unexpected and must be rigorously researched 
to ensure the trend is real and not merely a symptom of errors or inherent limitations of the methods 
used to gather the data. To verify the trend shown using FACS, confocal microscopy was also used to 
visually inspect the internalized CTx-488. The images shown below are taken from a mid-level section, 
clearly discerning the cell nuclear membrane. This ensures the plane at which each image was taken 
did not vary between the different IFN treatment lengths and the images clearly show cells with intact 
nuclear membranes. 
Shown below, the differences visible from the 0 h IFN treated and 24 h IFN treated samples (Figure 
3.2 and 3.3) are not quite as apparent; however, the differences from 0 h IFN treated and 48 h IFN 
treated samples (Figure 3.2 and 3.4) are stark. Although the differences shown in Figures 2.1-2.3 may 
seem small, as evident in the histograms, the confocal microscopy images prove these differences are 
detectable by the naked eye. The data shown in Figures 3.2-3.4 support the data gathered using 
FACS.  
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Figure 3.2: (A-F) Confocal scanning laser microscopy images showing CTx-488 (green) staining in 
fixed 3T3 murine fibroblast cells with no IFN treatment. The red DiD plasma membrane stain was not 
shown to display the green CTx-488 more easily. 
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Figure 3.3: (A-F) Confocal scanning laser microscopy images showing CTx-488 (green) staining in 
fixed 3T3 murine fibroblast cells after 24 h of IFN treatment. The red DiD plasma membrane stain was 
not shown to display the green CTx-488 more easily. 
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Figure 3.4: (A-F) Confocal scanning laser microscopy images showing CTx-488 (green) staining in 
fixed 3T3 murine fibroblast cells after 48 h of IFN treatment. The red DiD plasma membrane stain was 
not shown to display the green CTx-488 more easily. 
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CHAPTER 4: CONCLUSIONS AND FUTURE DIRECTIONS 
 
In summary, the data shown suggest an increasing caveolae-dependent endocytosis trend 
following interferon treatment. Verifying that CTx-488 was actually internalized was vital to determine 
whether endocytosis, as opposed to other means of plasma membrane penetration, was being 
measured. Two methods were used to prove the internal location of CTx-488. In agreement with the 
flow cytometry data, confocal microscopy imaging confirmed CTx endocytosis was up-regulated in IFN-
treated cells. Both FACS with trypan blue and confocal microscopy using a plasma membrane stain 
were also used to validate an intact cell membrane.  
These results challenge the simplistic notion that endocytosis would be down-regulated following 
IFN treatment so as to prevent perceived pathogens from gaining access into the cell. These findings 
point to a much more complex regulation of caveolae. Caveolae-dependent endocytosis may exist as 
two distinct pathways, one to the endoplasmic reticulum (ER) and one to the Golgi Apparatus82. With 
two separate pathways linked to one plasma membrane marker, namely caveolin, each separate 
pathway may include multiple levels of regulation not only at the plasma membrane where caveolae are 
located, but also internally along each endocytosis pathway. This knowledge suggests caveolae also 
serve as an important signaling pathway, with the abilities to direct cargo to specific locations within the 
cell. This signaling role of caveolae may be the true target of IFN, rather than their endocytosis-ability. 
It is important to note that CTx may also be internalized into cells via non-caveolae-dependent 
pathways. CTx has been shown to enter cells through the clathrin-mediated endocytosis pathway, 
however, the portion is minor and caveolae is thought to be the major entry pathway in NIH 3T3 cells82.  
Future experiments will employ chlorpromazine to block clathrin-mediated endocytosis and ensure 
caveolae-specific internalization of the aforementioned fluorescent-conjugate83,84. 
As mentioned in Chapter 1, IFN manipulates plasma membrane components, such as cholesterol, 
that are important to caveolae. Due to the interesting trend outlined in this work, the future direction of 
this project will explore IFN manipulation of cell plasma membrane components. Identification of IFN-
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induced alteration of the abundance of cholesterol and/or sphingolipids at caveolae requires the ability 
to image cholesterol, sphingolipids, and caveolae- or clathrin-specific membrane proteins without using 
bulky labels that may alter component organization (i.e., fluorophores)85–88. For this purpose, we will 
use high-resolution secondary ion mass spectrometry (SIMS) to chemically image the distributions of 
metabolically incorporated, isotope-labeled cholesterol and sphingolipids, and protein-specific 
immunolabels in the plasma membranes of IFN-treated and untreated cells. Statistical analysis of the 
resulting compositional maps will allow quantitative assessment of differences in the local composition 
of caveolae. This technique combines high sensitivity with a lateral resolution as high as 90 nm to allow 
mapping the elemental and isotopic composition at the surface (top 5 nm) of a biological sample. In the 
analyses a primary cesium ion beam is scanned over the surface of the sample (i.e., a cell). 
Monoatomic and diatomic secondary ions, which are charged fragments of the molecules that were 
located on the sample surface, with up to five different mass-to-charge ratios (m/z) are collected in 
parallel at every pixel (Figure 4.1).  
 
 
 
 
 
 
 
 
 
Figure 4.1: Depiction of NanoSIMS 
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The intensities of these secondary ions are then used to map the element and isotope composition 
at the sample surface. Because this instrument detects monoatomic and diatomic secondary ions, each 
species of interest must contain a distinct stable isotope so that the secondary ions generated during 
NanoSIMS analysis can be linked to the parent molecule. The distinct stable isotopes that encode for 
component identity are selectively incorporated into the lipid species of interest with established 
metabolic labeling techniques89–91. NanoSIMS analysis is performed under ultra-high vacuum, so 
sample preparation methods that preserve the intricate organization of the cellular membrane are 
required. Established fixation methods are used to preserve the spatial arrangement of the membrane 
biomolecules92. 
Though these SIMS experiments will not directly link IFN-induced cell membrane changes to 
caveolae-mediated endocytosis, it will investigate a possible mechanism of endocytosis control that 
may help to explain the interesting trends found in Chapters 2 and 3. Successful completion of the 
future research will shed new light onto the IFN response and its ability to modulate the plasma 
membrane and caveolae-mediated endocytosis. 
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